Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells

Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674

High-Efficiency Transformation of Mammalian Cells by Plasmid DNA

Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES

Todaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,747

Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100

Tumor promotion by caspase-resistant retinoblastoma protein

Borges, H. L., Bird, J., Wasson, K., Cardiff, R. D., Varki, N. M., Eckmann, L., & Wang, J. Y. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503925102 · Cited by 31

Glioma models

Dai, C., & Holland, E. C. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00027-0 · Cited by 31

A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins

Wadhwa, R., Sugihara, T., Hasan, M. K., Taira, K., Reddel, R. R., & Kaul, S. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203222200 · Cited by 31

p14ARF Protein Expression Is a Predictor of Both Relapse and Survival in Squamous Cell Carcinoma of the Anterior Tongue

Kwong, R. A., Kalish, L. H., Nguyen, T. V., Kench, J. G., Bova, R., Cole, I. E., Musgrove, E. A., & Sutherland, R. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2036 · Cited by 31

HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells

Arima, N., Arimura, K., Tokito, Y., Sakaki, Y., Matsushita, K., Orihara, K., Akimoto, M., Ozaki, A., Kukita, T., Hagiwara, T., et al. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2003.11.008 · Cited by 29

The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia

González‐Gil, C., Ribera, J., Ribera, J., & Genescà, E. (2021) · Genes · doi:10.3390/genes12010079 · Cited by 32

Modulation of the ARF-p53 Pathway by the Small DNA Tumor Viruses

O’Shea, C. C., & Fried, M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1555 · Cited by 29

Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8

Bello, M., Campos, J. D., Isla, A., Casartelli, C., & REY, J. A. (2006) · Oncology Reports · doi:10.3892/or.15.2.443 · Cited by 30

What has been Learned from the Studies of Oxidative Stress-induced Carcinogenesis: Proposal of the Concept of Oxygenomics

Toyokuni, S., & Akatsuka, S. (2006) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.39.3 · Cited by 30

A functional link between the tumour suppressors ARF and p33ING1

Gonzalez, L. C., Freije, J. M. P., Cal, S., López-Otı́n, C., Serrano, M., & Palmero, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209526 · Cited by 30

Decreased Mdm2 expression inhibits tumor development induced by loss of ARF

Wang, P., Greiner, T. C., Lushnikova, T., & Eischen, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209411 · Cited by 29

Molecularly targeted therapies for glioma

Yamanaka, R., & Saya, H. (2009) · Annals of Neurology · doi:10.1002/ana.21793 · Cited by 29

Evidence that Proteasome-Dependent Degradation of the Retinoblastoma Protein in Cells Lacking A-Type Lamins Occurs Independently of Gankyrin and MDM2

Nitta, R. T., Smith, C. L., & Kennedy, B. K. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000963 · Cited by 30

Decreased survival of C/EBPβ-deficient keratinocytes is due to aberrant regulation of p53 levels and function

Yoon, K., Zhu, S., Ewing, S. J., & Smart, R. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209797 · Cited by 28

IGF-1 activates p21 to inhibit UV-induced cell death

Murray, S. A., Zheng, H., Gu, L., & Xiao, Z. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206327 · Cited by 30

Functional analysis of p53 tumor suppressor in yeast

Šmardová, J., Šmarda, J., & Koptíková, J. (2005) · Differentiation · doi:10.1111/j.1432-0436.2005.00028.x · Cited by 29

p53-independent apoptosis is induced by the p19ARF tumor suppressor

Tsuji, K., Mizumoto, K., Sudo, H., Kouyama, K., Ogata, E., & Matsuoka, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00723-4 · Cited by 29

Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer

Maemondo, M., Saijo, Y., Narumi, K., Kikuchi, T., Usui, K., Tazawa, R., Matsumoto, K., Nakamura, T., Sasaki, K., Takahashi, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2549 · Cited by 28

Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein–Barr virus or T cell-derived mitogens

O’Nions, J., & Allday, M. J. (2004) · Journal of General Virology · doi:10.1099/vir.0.19704-0 · Cited by 29

Regulatory Network of ARF in Cancer Development.

Ko, A., Han, S. Y., & Song, J. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0100 · Cited by 27

Enhanced tumor suppression by a p14ARF/p53 bicistronic adenovirus through increased p53 protein translation and stability.

Huang, Y., Tyler, T., Saadatmandi, N., Lee, C., Borgström, P., & Gjerset, R. A. (2003) · PubMed · Cited by 28

A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53

Stanelle, J., Tu-Rapp, H., & Pützer, B. M. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401532 · Cited by 28

Genetic Modeling of Glioma Formation in Mice

Begemann, M., Fuller, G. N., & Holland, E. C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00428.x · Cited by 28

Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis

Chambon, V., Vacher, M., Jullien, M., May, E., & Bourdon, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203960 · Cited by 28

Genetic dissection of melanoma pathways in the mouse

Yang, F. C., Merlino, G. T., & Chin, L. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0376 · Cited by 28

MDM2’s dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities

Gnanasundram, S. V., Malbert-Colas, L., Chen, S., Fusée, L. T. S., Daskalogianni, C., Müller, P., Salomao, N., & Fåhræus, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa431 · Cited by 28

p73β-expressing recombinant adenovirus: a potential anticancer agent

Das, S., Nama, S., Antony, S., & Somasundaram, K. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700803 · Cited by 27

From tumor prevention to therapy: Empowering p53 to fight back

Frezza, C., & Martins, C. P. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.10.001 · Cited by 27

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis

Lаgopati, N., Belogiannis, K., Angelopoulou, A., Papaspyropoulos, A., & Gorgoulis, V. G. (2021) · Biomolecules · doi:10.3390/biom11010086 · Cited by 30

Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids

Viola, J. R., Rafael, D. F. D. S., Wagner, E., Besch, R., & Ogris, M. (2013) · Journal of Drug Delivery · doi:10.1155/2013/897348 · Cited by 27

Deregulation of the Cell Cycle by the Epstein–Barr Virus

O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 28

Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73β

Das, S., El‐Deiry, W. S., & Somasundaram, K. (2003) · Oncogene · doi:10.1038/sj.onc.1206908 · Cited by 27

The ARF/Oncogene Pathway Activates p53 Acetylation within the DNA Binding Domain

Mellert, H. S., Sykes, S. M., Murphy, M. E., & McMahon, S. B. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4343 · Cited by 32

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background

Guijarro, M. V., Nawab, A., Dib, P., Burkett, S. S., Luo, X., Feely, M., Nasri, E., Seifert, R. P., Kaye, F. J., & Zajac‐Kaye, M. (2023) · Oncogene · doi:10.1038/s41388-023-02694-7 · Cited by 26

The cellular abundance of the essential transcription termination factor TTF-I regulates ribosome biogenesis and is determined by MDM2 ubiquitinylation

Lessard, F., Stefanovsky, V. Y., Tremblay, M. G., & Moss, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks198 · Cited by 27

ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation

Miao, L., Song, Z., Jin, L., Zhu, Y., Wen, L., & Wu, M. (2009) · Oncogene · doi:10.1038/onc.2009.372 · Cited by 26

p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors

Yu, D., Carroll, M. P., & Thomas‐Tikhonenko, A. (2007) · Blood · doi:10.1182/blood-2006-10-050294 · Cited by 26

Integration of the PRB and P53 Cell Cycle Control Pathways

Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27

Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells

Thomas, S. L., Deadwyler, G., Tang, J. M., Stubbs, E. B., Muir, D., Hiatt, K. K., Clapp, D. W., & Vries, G. H. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.159 · Cited by 29

The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

D’Amico, M., Wu, K., Vizio, D. D., Reutens, A. T., Stahl, M. C., Fu, M., Albanese, C., Russell, R. G., Muller, W. J., White, M. A., et al. (2003) · PubMed · Cited by 26

Human p14Arf: an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function

David-Pfeuty, T., & Nouvian-Dooghe, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205871 · Cited by 26

Familial Melanoma; CDKN2A and Beyond

Gruis, N. A., van der Velden, P. A., Bergman, W., & Frants, R. R. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640181 · Cited by 26

Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesis

Herzog, C. R., Noh, S. J., Lantry, L. E., Guan, K.-L., & You, M. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199906)25:2 · Cited by 26

The DNA Damage Checkpoint and Human CancerPreprint

Schultz, L. B., Chehab, N. H., Malikzay, A., DiTullio, R. A., Stavridi, E. S., & Halazonetis, T. D. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.489 · Cited by 26

Collaborator of alternative reading frame protein (CARF) regulates early processing of pre-ribosomal RNA by retaining XRN2 (5′-3′ exoribonuclease) in the nucleoplasm

Sato, S., Ishikawa, H., Yoshikawa, H., Izumikawa, K., Simpson, R. J., & Takahashi, N. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1069 · Cited by 24

The promiscuity of ARF interactions with the proteasome

Pollice, A., Vivo, M., & Mantia, G. L. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.09.026 · Cited by 28

Epstein‐Barr virus‐encoded EBNA‐5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53

Kashuba, E., Yurchenko, M., Yenamandra, S. P., Снопок, Б. А., Székely, L., Bercovich, B., Ciechanover, A. J., & Klein, G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25414 · Cited by 28

3-Morpholinosydnonimine Hydrochloride Induces p53-Dependent Apoptosis in Murine Primary Neural Cells: A Critical Role for p21ras–MAPK–p19ARF Pathway

Kaji, T., Kaieda, I., Hisatsune, T., & Kaminogawa, S. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0389 · Cited by 25

CDKN2A (p14ARF/p16INK4a) and ATM promoter methylation in patients with impalpable breast lesions

Delmonico, L., Moreira, A. D. S., Franco, M. F., Esteves, E. B., Scherrer, L. R., Gallo, C. V. D. M., do Nascimento, C. M., Ornellas, M. H., de Azevedo, C. M., & Alves, G. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.06.016 · Cited by 24

A highly sensitive fluorescent light-up probe for real-time detection of the endogenous protein target and its antagonism in live cells

Geng, J., Goh, W. L., Zhang, C., Lane, D. P., Liu, B., Ghadessy, F. J., & Tan, Y. N. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00819k · Cited by 24

Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities

Tommaso, A. D., Hagen, J., Tompkins, V. S., Muniz, V. P., Dudakovic, A., Kitzis, A., Ladevèze, V., & Quelle, D. E. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.01.010 · Cited by 23

NMI mediates transcription-independent ARF regulation in response to cellular stresses

Li, Z., Hou, J., Sun, L., Wen, T., Wang, L., Zhao, X., Xie, Q., & Zhang, S. Q. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-04-0304 · Cited by 25

A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression

Zhang, Z., Wang, Y., Herzog, C. R., Liu, G., Lee, H., DePinho, R. A., & You, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205725 · Cited by 24

p53 in breast cancer: mutation and countermeasures

Kumar, S. R. (2007) · Frontiers in bioscience · doi:10.2741/2378 · Cited by 24

Adenovirus-Mediated p14 ARF Gene Transfer Cooperates with Ad5CMV-p53 to Induce Apoptosis in Human Cancer Cells

Tango, Y., Fujiwara, T., Itoshima, T., Takata, Y., Katsuda, K., Uno, F., Ohtani, S., Tani, T., Roth, J. A., & Tanaka, N. (2002) · Human Gene Therapy · doi:10.1089/104303402760128595 · Cited by 24

Loss of p19 ARF Eliminates the Requirement for the pRB-Binding Motif in Simian Virus 40 Large T Antigen-Mediated Transformation

Chao, H. H., Buchmann, A. M., & DeCaprio, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7624-7633.2000 · Cited by 25

Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.

Hyde, R. K., & Griep, A. E. (2002) · PubMed · Cited by 24

Dissociation of Bone Morphogenetic Protein-Mediated Growth Arrest and Apoptosis of Mouse B Cells by HPV-16 E6/E7

Yamato, K., Hashimoto, S., Okahashi, N., Ishisaki, A., Nonaka, K., Koseki, T., Kizaki, M., Ikeda, Y., & Nishihara, T. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4876 · Cited by 24

The molecular biology of WHO grade II gliomas.

Marko, N. F., & Weil, R. (2013) · Neurosurgical Focus · doi:10.3171/2012.12.focus12283 · Cited by 20

Epstein-Barr Virus Nuclear Antigen 3A Promotes Cellular Proliferation by Repression of the Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1

Tursiella, M. L., Bowman, E., Wanzeck, K. C., Throm, R. E., Liao, J., Zhu, J., & Sample, C. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004415 · Cited by 23

p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.

Divan, A., Lawry, J., DUNSMORE, I. R., Parsons, M. A., & Royds, J. A. (2001) · PubMed · Cited by 22

Peli1 Modulates the Subcellular Localization and Activity of Mdmx

Li, D., Tavana, O., Sun, S., & Gu, W. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3531 · Cited by 22

The p27 Pathway Modulates the Regulation of Skeletal Growth and Osteoblastic Bone Formation by Parathyroid Hormone–Related Peptide

Zhu, M., Zhang, J., Zhan, D., Zhang, Y., Wang, R., Karaplis, A. C., Goltzman, D., & Miao, D. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2544 · Cited by 24

Physical and Functional Interaction of the p14ARF Tumor Suppressor with Ribosomes

Rizos, H., McKenzie, H. A., Ayub, A. L. P., Woodruff, S., Becker, T. M., Scurr, L. L., Stahl, J., & Kefford, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609405200 · Cited by 23

Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma

Yamada, Y., & Kamihira, S. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500244217 · Cited by 24

Post-Translational Regulation of ARF: Perspective in Cancer

Seo, J., Seong, D., Lee, S. R., Oh, D., & Song, J. (2020) · Biomolecules · doi:10.3390/biom10081143 · Cited by 25

Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1–MDM2–p53 Pathway

Qin, J., Wang, W., & Zhang, R. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.005 · Cited by 22

Effect of adipose-derived stem cell-conditioned medium on the proliferation and migration of B16 melanoma cells

Lee, J., Park, C., Chun, K., & Hong, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.3360 · Cited by 23

Resistance of CD1d−/− Mice to Ultraviolet-Induced Skin Cancer Is Associated with Increased Apoptosis

Matsumura, Y., Moodycliffe, A. M., Nghiem, D. X., Ullrich, S. E., & Ananthaswamy, H. N. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63350-0 · Cited by 21

Loss of p14ARF expression in melanoma

Dobrowolski, R., Hein, R., Buettner, R., & Bosserhoff, A. (2001) · Archives of Dermatological Research · doi:10.1007/s00403-001-0274-y · Cited by 22

Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets

Ghimenti, C., Fiano, V., Chiadò-Piat, L., Chiò, A., Cavalla, P., & Schiffer, D. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022127302008 · Cited by 21

Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma

Vettore, A. L., Sonaglio, de Carvalho, A. C., Toledo, S., Carvalho, de Camargo, B., Salinas-Souza, C., & Petrilli (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44918 · Cited by 21

Cell fate conversion: Direct induction of hepatocyte‐like cells from fibroblasts

Ji, S., Zhang, L., & Hui, L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24380 · Cited by 21

p53-dependent control of transactivation of the Pen2 promoter by presenilins

Dunys, J., Sévalle, J., Giaime, E., Pardossi‐Piquard, R., Vitek, M. P., Renbaum, P., Levy‐Lahad, E., Zhang, Y., Xu, H., Checler, F., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.051169 · Cited by 21

Identification and Characterization of Two Novel Isoforms of Pirh2 Ubiquitin Ligase That Negatively Regulate p53 Independent of RING Finger Domains

Corcoran, C. A., Montalbano, J., Hong, S., He, Q., Huang, Y. K., & Sheikh, M. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024232 · Cited by 22

Impact of Cellular Senescence in Aging and Cancer

Provinciali, M., Cardelli, M., Marchegiani, F., & Pierpaoli, E. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219739 · Cited by 21

Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas

Meléndez, B., Malumbres, M., de Castro, I. P., Santos, J., Pellicer, À., & Fernández‐Piqueras, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.817 · Cited by 21

Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas

Bisogna, M., Calvano, J. E., Ho, G. H., Orlow, I., Cordon‐Cardo, C., Borgen, P. I., & Zee, K. J. V. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00367-8 · Cited by 21

A Locus Linked to p16 Modifies Melanoma Risk in Dutch Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome FamiliesPreprint

van der Velden, P. A., Sandkuijl, L. A., Bergman, W., Hille, E. T. M., Frants, R. R., & Gruis, N. A. (1999) · Genome Research · doi:10.1101/gr.9.6.575 · Cited by 21

The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions

Ponti, D., Bastianelli, D., Rosa, P., Pacini, L., Ibrahim, M., Rendina, E. A., Ragona, G., & Calogero, A. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0073-5 · Cited by 20

The p53 Tumor Suppressor Pathway and Cancer

Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20

Id2 Is Dispensable for Myc-Induced Lymphomagenesis

Nilsson, J. A., Nilsson, L. M., Keller, U. B., Yokota, Y., Boyd, K. L., & Cleveland, J. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2133 · Cited by 20

Growth suppression by a p14ARF exon 1β adenovirus in human tumor cell lines of varying p53 and Rb status

Saadatmandi, N., Tyler, T., Huang, Y., Haghighi, A. P., Frost, G., Borgström, P., & Gjerset, R. A. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700505 · Cited by 20

Dissecting the Contribution of p16INK4A and the Rb Family to the Ras Transformed Phenotype

Mitchell, P. J., Pérez‐Nadales, E., Malcolm, D. S., & Lloyd, A. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2530-2542.2003 · Cited by 20

Nucleolar p14ARF Overexpression in Reed-Sternberg Cells in Hodgkin's Lymphoma

García, J. F., Villuendas, R., Sánchez‐Beato, M., Sánchez‐Aguilera, A., Sánchez, L., Priéto, I., & Piris, M. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64876-6 · Cited by 20

Regulation of p53-dependent transcription

Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20

CDK inhibitors for muscle stem cell differentiation and self-renewal

Mohan, A., & Asakura, A. (2017) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.6.65 · Cited by 18

Molecular bridging of aging and cancer

Cheung, C., Kaul, S. C., & Wadhwa, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05392.x · Cited by 20

Novel murine B‐cell lymphoma/leukemia model to study BCL2‐driven oncogenesis

Meijerink, J. P. P., Lieshout, E. M. M. V., Beverloo, H. B., van Drunen, E., Mensink, E. J. B. M., Macville, M. V. E., & Pieters, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20822 · Cited by 19

DNA Replication Licensing Factor Minichromosome Maintenance Deficient 5 Rescues p53-Mediated Growth Arrest

Agarwal, M. K., Amin, A. R. M. R., & Agarwal, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2835 · Cited by 19

Loss of p14ARF confers resistance to heat shock‐ and oxidative stress‐mediated cell death by upregulating β‐catenin

Damalas, A., Velimezi, G., Kalaitzakis, A., Liontos, M., Papavassiliou, A. G., Gorgoulis, V. G., & Angelidis, C. E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25510 · Cited by 20

The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression

Pan, W., Issaq, S. H., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021625 · Cited by 18

Emerging treatment options for patients with p53-pathway-deficient CLL

Aitken, M. J. L., Lee, H. J., & Post, S. M. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620719891356 · Cited by 20

p14ARFis capable of promoting HIV-1 Tat degradation

Gargano, B., Fiorillo, M., Amente, S., Majello, B., & Lania, L. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5878 · Cited by 18

p19ARFDetermines the Balance between Normal Cell Proliferation Rate and Apoptosis during Mammary Gland Development

Yi, Y., Shepard, A., Kittrell, F. S., Mulac‐Jeričević, B., Medina, D., & Said, T. K. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0785 · Cited by 18

Modeling malignant melanoma in mice: pathogenesis and maintenance

Chin, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203106 · Cited by 18

B Lymphoid Neoplasms of Mice: Characteristics of Naturally Occurring and Engineered Diseases and Relationships to Human Disorders

Morse, H. C., McCarty, T. C., Qi, C., Torrey, T. A., Naghashfar, Z., Chattopadhyay, S. K., Fredrickson, T. N., & Hartley, J. W. (2003) · Advances in immunology · doi:10.1016/s0065-2776(03)81003-9 · Cited by 18

miR-34a is essential for p19Arf-driven cell cycle arrest

Iqbal, N. S., Mei, J., Liu, J., & Skapek, S. X. (2014) · Cell Cycle · doi:10.4161/cc.27725 · Cited by 17

p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours

Dimitriadi, M., Poulogiannis, G., Liu, L., Bäcklund, L. M., Pearson, D. M., Ichimura, K., & Collins, V. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604643 · Cited by 17

cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response

Madapura, H. S., Salamon, D., Wiman, K. G., Laı́n, S., Klein, E., & Nagy, N. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1160975 · Cited by 18

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521

Nucleolar Arf sequesters Mdm2 and activates p53

Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940

Human tumor suppressor ARF impedes S-phase progression independent of p53.

Yarbrough, W. G., Bessho, M., Zanation, A. M., Bisi, J., & Xiong, Y. (2002) · PubMed · Cited by 51

Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res

Yarbrough, W. G., Bessho, M., Zanation, A. M., Bisi, J., & Xiong, Y. (2002)